Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FBIOP | ||||
| Company | Fortress Biotech Inc 9.375% Series A Cumulativ | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 13.45 | ||||
| High | 13.86 | ||||
| Low | 13.35 | ||||
| Latest | 13.59 | ||||
| Change | +0.03 | ||||
| % Change | +0.26% | ||||
| Volume | 12,500 | ||||
| 20-Day Average Volume | 17,200 | ||||
| Previous Close | 13.55 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 13.51 | ||||
| 20-Day Raw Stochastic | 60.28% | ||||
| 20-Day Relative Strength | 56.28 | ||||
| Weighted Alpha | +111.78 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 100% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 03/26/26 | ||||
| Low | 13.15 on 03/30/26 | ||||
| High | 14.30 on 04/01/26 | ||||
| 1-Month | |||||
| %Chg | -4.47% since 03/02/26 | ||||
| Low | 12.50 on 03/13/26 | ||||
| High | 14.37 on 03/04/26 | ||||
| 3-Month | |||||
| %Chg | +33.71% since 01/02/26 | ||||
| Low | 9.65 on 01/08/26 | ||||
| High | 14.64 on 03/02/26 | ||||
| 6-Month | |||||
| %Chg | +86.86% since 10/02/25 | ||||
| Low | 6.27 on 11/14/25 | ||||
| High | 14.64 on 03/02/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 63,262,000 | ||||
| Annual Net Income | 6,815,000 | ||||
| Last Quarter Sales | 16,079,000 | ||||
| Last Quarter Net Income | -3,937,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||